HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 949-960 of 4,505
Drug study icon
CompletedNCT05326347

A Long-term Administration study of Brexpiprazole Once-weekly (QW) Formulation in people with Schizophrenia

What is this study about?

Researchers studied OPC-34712FUM/ Brexpiprazole fumarate, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.

This study has finished and is no longer accepting participants.

In Kure-shi
SchizophreniaMedication studyAges 18–74
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Drug study icon
CompletedNCT01626859

A Pharmacokinetic Study of MP-214 in people with Schizophrenia

Official study title

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia (12 Weeks Treatment Study)

This study has finished and is no longer accepting participants.

In Sakai
SchizophreniaMedication studyAges 20–64
Countries
Japan
Sponsor
Tanabe Pharma Corporation
Drug study icon
CompletedNCT04158687

Safety and Efficacy of CTP-692 for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of CTP-692 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Concert Pharmaceuticals
Drug study icon
CompletedNCT01614899

A Phase III Study of SM-13496 (Lurasidone HCl) in people with Schizophrenia

What is this study about?

Researchers compared SM-13496 40mg, SM-13496 80mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Tokyo, Etc
SchizophreniaMedication studyAges 18–74
Countries
Japan, Malaysia, South Korea, + 1 other
Sponsor
Sumitomo Pharma Co., Ltd.
Drug study icon
CompletedNCT01452919

A Physical Dependence Study in Schizophrenia

Official study title

A Phase 3, Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of LY2140023 Monohydrate in Patients With DSM-IV-TR Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Oakland
SchizophreniaMedication studyAges 18–65
Countries
United States, Greece
Sponsor
Denovo Biopharma LLC
Device study icon
CompletedNCT06791122

Effectiveness of investigational Digital Therapeutic in schizophrenia

Official study title

A Multicenter, Pragmatic Study to Evaluate Clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Imperial
SchizophreniaDevice studyAges 18+
Countries
United States
Sponsor
Boehringer Ingelheim
Drug study icon
CompletedNCT05693935

TV-44749 for schizophrenia

What is this study about?

Researchers compared TV-44749 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Bentonville
SchizophreniaMedication studyAges 18–64
Countries
United States, Bulgaria, China, + 2 others
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Drug study icon
CompletedNCT01051531

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to people with Schizophrenia

What is this study about?

Researchers studied Paliperidone palmitate to find out how it affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Dandenong
SchizophreniaMedication studyAges 18–50
Countries
Australia, New Zealand, China, + 5 others
Sponsor
Janssen Research & Development, LLC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.